Search Results
Results found for "Crinetics"
- 📰 GPCR Weekly News, September 18 to 24, 2023
Post-Doc Research Associate Research Technician Senior Research Associate, In Vitro Pharmacology - Crinetics
- 📰 GPCR Weekly News, September 11 to 17, 2023
Post-Doc Research Associate NEW Research Technician Senior Research Associate, In Vitro Pharmacology - Crinetics
- 📰 GPCR Weekly News, February 26 to March 3, 2024
Domain Therapeutics announces the promotion of Stephan Schann to the role of Chief Scientific Officer Crinetics
- 📰 GPCR Weekly News, July 31 to August 6, 2023
major adverse cardiovascular events by 20% in adults with overweight or obesity in the SELECT trial Crinetics
- Unlocking the Future of Medicine: Advancements in GPCR Research
to deliver strong sales growth and core margin expansion in Q2; raises FY 2024 bottom-line guidance Crinetics
- 📰 GPCR Weekly News, April 22 to 28, 2024
had a great conversation about this position with Beth Fleck, Director of In Vitro Pharmacology at Crinetics
- 📰 GPCR Weekly News, April 15 to 21, 2024
had a great conversation about this position with Beth Fleck, Director of In Vitro Pharmacology at Crinetics
- 📢 Early Bird Registration Ends Tomorrow! | Sep 16 - 22, 2024
promising results for metabolic disorders INDIGO Biosciences, INC as a Preferred Supplier at Prendio Crinetics
- Competitive vs Non-Competitive GPCR Antagonists: How to Interpret Pharmacology Data with Confidence
to unlock elusive GPCR targets, financial results from Neurocrine Biosciences, and a deep dive into Crinetics
- 📰 GPCR Weekly News, February 12 to 18, 2024
Industry News InterAx Biotech's AI platform unlocks new drug designs for diabetes, obesity, and cancer Crinetics
- 📰 GPCR Weekly News, February 20 to 26, 2023
Industry News Josephine (Pina) Cardarelli from GPCR Therapeutics on Beyond Biotech Podcast Crinetics
- 📰 GPCR Weekly News, June 17 to 23, 2024
peptide QRFP receptor GPR103 Industry News EY Announces Scott Struthers, Ph.D., CEO and Founder of Crinetics
- ⛵Sailing the GPCR Seas: Your Weekly Research Voyage! ⦿ Nov 11 - 17, 2024
November 11th to 17th, 2024 Industry News Centessa Launches Phase 2 Trial of ORX750 for Narcolepsy and IH Crinetics
- 📰 GPCR Weekly News, May 13 to 19, 2024
Mark discussed this position with Beth Fleck, Director of In Vitro Pharmacology at Crinetics Pharmaceuticals
- 📰 GPCR Weekly News, March 25 to March 31, 2024
Latest Data on DT-9045, a First-in-class Negative Allosteric Modulator of PAR2 for Immuno-oncology Crinetics







